GBC Blog

Epigenomics AG: China FDA names Epigenomics’ blood-based Septin9 colorectal cancer test a most innovative medical product for 2015 Berlin (Germany) and Germantown, MD (U.S.A.), May 2, 2016 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), the German-American cancer molecular diagnostics company, announced today that the China Food and Drug Administration (CFDA) has named the…

From LABIOTECH.EU http://labiotech.eu/epigenomics-epiprocolon-interview-blood-test-cancer-colon-diagnostics-us/ We met the Biotech that just launched the First & Only Blood Test for Colorectal Cancer in the US 14/04/2016 Colorectal cancer is the second biggest Cancer killer in the US. This sad figure could be dramatically improved if the diagnostic would be more effective. A problem Berlin-based Epigenomics want to solve and just got…

Apr. 13, 2016 2:19 PM ET In pulling off the almost unheard-of feat of successfully appealing against an FDA rejection, Epigenomics (OTCQX:EPGNF) today got full approval for its twice-denied colon cancer blood test, saw its share price rise 24%, and shone a light on some rather odd behavior from the US regulator. “We had a…

12-April-2016 Curetis AG / Curetis Publishes Full-Year 2015 Financial Results and Introduces 2016 Guidance . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. – Company successfully completed IPO on Euronext Amsterdam and Euronext Brussels, raising EUR 44.3 million  – Accelerated global commercialization lays strong…

http://www.japantimes.co.jp/news/2016/04/12/national/science-health/massive-whole-genome-study-finds-six-types-of-liver-cancer/#.Vw5qsJMrIUE

BioChain Acquires China Rights To Epigenomics AG Lung Cancer IVD [4/6/2016] BioChain, a US-China diagnostics/genomics tools company, has in-licensed China rights to a novel blood-based lung cancer diagnostic test from Epigenomics of Germany. BioChain will conduct China clinical trials for approval of the test in China and then commercialize it. In 2013, BioChain and Epigonomics…

View press release here: http://www.prnewswire.com/news-releases/cryoport-chosen-to-provide-cold-chain-logistics-support-to-proteogenex-300245387.html

Epigenomics Enters Agreement with Biochain on Lung Cancer Test for China March 30, 2016 Epigenomics AG : * Enters strategic license and development agreement with Biochain on novel, blood-based lung cancer test for China * Will receive undisclosed upfront, milestone and minimum annual payments as well as mid single-digit royalty on future revenues * Biochain…